Clinical Trial Update: A Study of Gemcitabine, Epirubicin, and Paclitaxel Combination Chemotherapy Given Before Surgery to Patients With Locally Advanced Breast Cancer [Phase 2]

View source ↗

Summary

This Phase 2 trial assesses a preoperative combination of gemcitabine, epirubicin, and paclitaxel in locally advanced breast cancer; the study is completed. It …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Epirubicin (epirubicin)
• Gemcitabine (Gemcitabine)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: NSABP Foundation Inc | Conditions: Stage IIB Breast Cancer, Stage IIIA Breast Cancer | Phase 2 | Status: COMPLETED